Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Breast Neoplasms 9 Prostatic Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain, Postoperative 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma 2 Hemorrhage 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Cyst 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurotoxicity Syndromes 1 Myofibroma 1 Multiple Myeloma 1 Metabolic Diseases 1 Melanoma 1

Interventions

ferric derisomaltose 2 iron isomaltoside 1000 1 ferric carboxymaltose 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Anemia, Iron-Deficiency × Saline Solution × Clear all

NCT05467319 2022-07-20

FORGE

Alberta Health Services, Calgary

Phase 3 Unknown

Classical hematology

Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡